Replies to post #2924 on Idera Pharmaceuticals Inc (IDRA)

[jaybe]

Key phrase is "we are increasingly encouraged with the data seen to date." Orphan status in itself is not a big deal, however with patent expiration in 2025, the 7-year exclusivity will be helpful. Of course assuming other TLR9's-CPI combos go after same indication.